Caxton Associates (New York)’s CNO Financial Group CNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$618K Sell
16,612
-7,649
-32% -$284K 0.02% 291
2024
Q3
$852K Buy
+24,261
New +$780K 0.03% 269
2023
Q2
Sell
-29,140
Closed -$647K 530
2023
Q1
$647K Buy
+29,140
New +$696K 0.1% 219
2022
Q4
Sell
-63,304
Closed -$1.14M 478
2022
Q3
$1.14M Hold
63,304
0.15% 90
2022
Q2
$1.15M Buy
63,304
+34,558
+120% +$739K 0.11% 93
2022
Q1
$721K Hold
28,746
0.06% 159
2021
Q4
$685K Sell
28,746
-3,312
-10% -$81.3K 0.07% 192
2021
Q3
$755K Buy
32,058
+5,321
+20% +$124K 0.08% 138
2021
Q2
$632K Buy
+26,737
New +$683K 0.07% 134
2020
Q1
Sell
-10,050
Closed -$182K 432
2019
Q4
$182K Sell
10,050
-26,474
-72% -$450K 0.03% 362
2019
Q3
$578K Buy
36,524
+23,529
+181% +$372K 0.11% 108
2019
Q2
$217K Buy
+12,995
New +$215K 0.03% 352

Other funds holding CNO

Caxton Associates (New York)'s CNO Position: Q4 2024 in Review

Caxton Associates (New York) reduced its CNO Financial Group (CNO) stake by 32% in Q4 2024, selling an estimated $284K and leaving 16,612 shares worth $618K. The position accounts for 0.02% of the portfolio, ranked #291.

Caxton Associates (New York) first reported a position in CNO in Q2 2019 and has held it in 12 quarters since. The position peaked at $1.15M in Q2 2022. 318 funds tracked by Wall St. Rank hold CNO as of Q4 2024.

  • Caxton Associates (New York) held 16,612 shares of CNO Financial Group worth $618K as of Q4 2024.
  • Caxton Associates (New York) sold 7,649 CNO Financial Group shares in Q4 2024, an estimated $284K.
  • CNO Financial Group made up 0.02% of Caxton Associates (New York)'s portfolio in Q4 2024, its #291 holding.
  • Caxton Associates (New York) first reported a position in CNO Financial Group in Q2 2019 and has held it in 12 quarters since.
  • Caxton Associates (New York)'s CNO Financial Group position peaked at $1.15M in Q2 2022.
  • 318 funds tracked by Wall St. Rank held CNO Financial Group as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.